.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Glaxosmithkline Company Profile

« Back to Dashboard

Summary for Applicant: Glaxosmithkline

Patents:61
Tradenames:112
Ingredients:94
NDAs:157
Drug Master File Entries: (click here to view)25
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline Llc
DYNACIRC CR
isradipine
TABLET, EXTENDED RELEASE;ORAL020336-001Jun 1, 1994DISCNNo<disabled><disabled>
Glaxosmithkline
TAGAMET
cimetidine
TABLET;ORAL017920-005Apr 30, 1986DISCNNo<disabled><disabled>
Glaxosmithkline
ZOVIRAX
acyclovir sodium
INJECTABLE;INJECTION018603-001Oct 22, 1982DISCNNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc